Skip to content
OpenCapital
Get started

Biote Corp. BTMD Gross margin

Gross margin at other companies

Target logo
TargetTGT
28.1%+0.1pp
Walmart logo
Walmart WMT
25%+0.1pp
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
31.3%-1.4pp
BioLife Solutions logo
BioLife SolutionsBLFS
66.9%—
NAG
Niagen Bioscience, Inc. Common StockNAGE
64.3%+1.8pp
Lifevantage Corporation logo
Lifevantage CorporationLFVN
78.1%-2.2pp

Other financials

Income statement

See full
Revenue$44.9M-8.3%
Gross profit$31.0M-14.9%
Operating income$3.2M-67.3%
Net income$2.3M-83.4%
EPS (diluted)$0.06-83.8%

Balance sheet

See full
Cash & equivalents$5.3M-87.2%
Total debt$103.4M-5.5%
Total equity-$56.1M+37.7%
Total assets$89.0M-27.8%

Cash flow

See full
Operating cash flow$3.9M-39.7%
CapEx$362.0K-77.8%
Free cash flow$3.5M-26.8%

Valuation

See full
Market cap$57.33M-51.2%
Enterprise value$155.43M-26.5%
P/E3.7×-0.1×
P/S0.3×-0.3×

Profitability

See full
Operating margin15.4%-0.1pp
Net margin8.3%-2.3pp
FCF margin15.3%-3.2pp

Returns & leverage

See full
Return on equity-21.4%—
Debt / equity9.1×—
Current ratio1.3×-0.1×

Where this comes from

Calculated from Biote Corp.’s reported figures.

gross profit/total revenue=70.1%

Based on trailing twelve months.

The official record: Biote Corp.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biote Corp.'s gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biote Corp.'s gross margin?
Biote Corp. (BTMD) reported gross margin of 70.1% in Q1 2026.
How has Biote Corp.'s gross margin changed year-over-year?
Biote Corp.'s gross margin decreased by 1.6% year-over-year, from 71.3% to 70.1%.
What is the long-term trend for Biote Corp.'s gross margin?
Over 4 years (2021 to 2025), Biote Corp.'s gross margin has grown at a 2.4% compound annual growth rate (CAGR), from 65% to 71.5%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.